Sartorius Finance BV, founded in 2019 and based in Amsterdam, serves as the financing arm of Sartorius AG, a global pharmaceutical and laboratory equipment supplier. The company is dedicated to providing innovative financing solutions that enhance Sartorius AG’s investment capabilities, ensuring robust support for the growth of its diverse product portfolio.
| Bond Name | Country | Maturity | Coupon(%) | |
|---|---|---|---|---|
| SRTGR 4.25% 2026-09-14 EURSartorius Finance BV | Netherlands | 2026-09-14 | 4.250 | 2.74 |
| SRTGR 4.38% 2029-09-14 EURSartorius Finance BV | Netherlands | 2029-09-14 | 4.375 | 3.07 |
| SRTGR 4.50% 2032-09-14 EURSartorius Finance BV | Netherlands | 2032-09-14 | 4.500 | 3.68 |
| SRTGR 4.88% 2035-09-14 EURSartorius Finance BV | Netherlands | 2035-09-14 | 4.875 | 4.06 |
Company overview and issue history are AI generated, and should not be cited or relied on without verification.
Sartorius Finance BV began issuing bonds shortly after its establishment, successfully launching its inaugural bond in 2020. Notably, the company issued a €300 million bond in 2021 to finance strategic acquisitions, showcasing its intent to strengthen its market position. As of October 2023, the current yields on Sartorius Finance BV’s bonds remain competitive within the industry, reflecting strong investor confidence amid favorable market conditions.